CCP positive individuals without Rheumatoid Arthritis
II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.
Barbara Davis Center
UCD Barbara Davis Center
University of Colorado Hospital
Kevin Deane, MD
Protocol Number: 15-1868
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers